| Summary points: | A 34-year-old male on prophylactic topiramate for migraine complains of blurred vision and ocular pain 7 days after topiramate initiation. The patient's medical history, current medications, neurological examination, ophthalmologic examination, treatment response, and outcome are described. The authors discuss the clinical symptoms of glaucoma and the risk of glaucoma associated with topiramate and selective serotonin reuptake inhibitors. |